Skip to main content

Table 1 Effect of artemisinin on salivary flow rate in mice

From: Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary Sjögren’s syndrome

GROUP

Salivary flow rate at 0 week(μl min-1)

Salivary flow rate at 8 week(μl min-1)

P

normal group

28.21 ± 2.35

24.97 ± 1.54

0.282

model group

28.98 ± 1.50

13.25 ± 1.72*

0.012

artemisinin group

28.94 ± 2.10

18.88 ± 3.10*#

0.060

HCQ group

28.96 ± 1.70

20.31 ± 0.62 *#

0.017

  1. *P < 0.05 compared with the normal group; #P < 0.05 compared with the model group
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us